drop glp 1 Researchers behind GLP-1 obesity drugs advance new approach: GLP-1 as a target Popular GLP-1 drugs help many
Description
According to the 2023 ADA standards of care in diabetes (12), GLP-1 RAs with demonstrated CV benefit are considered for T2DM patients with established ASCVD or at high risk for ASCVD to reduce the risk of MACE
doi: 10.3390/ijms23168942 157 ParkerJOBrienCHawrelakJGershFL

It is not possible to guarantee the drugs are safe, but women who used them before discovering they were pregnant neednt panic, she said
The combined effect of all three receptor pathways creates something researchers call a synergistic metabolic cascade

The drugs also appear to reduce neuroinflammation, scavenge free radicals, and limit damage to neurons

Additionally, factors secreted by retinal cells, like IL-6, promote the proliferation of different retinal cell types, contributing to the formation of new blood vessels and the progression of diabetic retinopathy (84)
